You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 52 No. 2, February 1995 TABLE OF CONTENTS
  Archives
  •  Online Features
  Original Contributions
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal

White Matter Hyperintensities in Parkinson's Disease

Clinical Correlations

Paola Piccini, MD; Nicola Pavese, MD; Raffaello Canapicchi, MD; Claudio Paoli, MD; Paolo Del Dotto, MD; Michele Puglioli, MD; Giuseppe Rossi, BioSc; Ubaldo Bonuccelli, MD

Arch Neurol. 1995;52(2):191-194.


Abstract

Objectives
To verify recent preliminary data indicating that white matter hyperintensities on magnetic resonance imaging are more abundant in patients with Parkinson's disease (PD) than in healthy subjects and to examine possible correlation between these abnormalities and clinical features of PD.

Design
Magnetic resonance imaging data on patients with PD and normal subjects were compared as to frequency, extent, and topographic location of white matter hyperintensities; moreover, in the PD group, we studied the possible correlation of white matter hyperintensities with clinical features such as severity, disease duration, and therapy.

Setting
The outpatient clinic of the Institute of Clinical Neurology and the Neuroradiology Unit of the University of Pisa (Italy).

Patients
We studied 102 nondemented patients with idiopathic PD and 68 sex- and age-matched healthy controls, all screened for absence of cerebrovascular risk factors.

Outcome Measures
White matter hyperintensities were classified as periventricular hyperintensities and deep hyperintensities. Frequency, extent, and topographic location of both periventricular and deep hyperintensities were evaluated. The clinical parameters examined were disease duration, treatment type, and disease severity (using Hoehn and Yahr staging and the Unified Parkinson's Disease Rating Scale), as well as disease progression index (ratio between Hoehn and Yahr stage and disease duration).

Results
The frequency and the extent of periventricular hyperintensities were significantly higher in patients with PD than in healthy subjects. Moreover, within the PD group, the patients who had periventricular hyperintensities had significantly shorter disease duration and greater disease severity, ie, a higher disease progression index, than those who did not.

Conclusion
These data suggest that periventricular hyperintensities may represent a marker for a clinical subtype of PD characterized by a more rapid neurodegenerative process.



Author Affiliations

From the Institute of Clinical Neurology (Drs Piccini, Pavese, Paoli, Del Dotto, and Bonuccelli) and the Neuroradiology Unit (Drs Canapicchi and Puglioli), University of Pisa, and the Institute of Clinical Physiology and the Biostatistics Unit, National Research Council (Dr Rossi), Pisa, Italy.



THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Clinical Correlates of Vascular Parkinsonism
Winikates and Jankovic
Arch Neurol 1999;56:98-102.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1995 American Medical Association. All Rights Reserved.